223.48
0.62%
1.38
After Hours:
223.48
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $223.48, with a volume of 462.59K.
It is up +0.62% in the last 24 hours and down -2.79% over the past month.
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$222.10
Open:
$223.01
24h Volume:
462.59K
Relative Volume:
0.87
Market Cap:
$18.76B
Revenue:
$12.49B
Net Income/Loss:
$449.50M
P/E Ratio:
29.88
EPS:
7.48
Net Cash Flow:
$852.30M
1W Performance:
-0.55%
1M Performance:
-2.79%
6M Performance:
+2.30%
1Y Performance:
+11.16%
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-09-24 | Initiated | Evercore ISI | In-line |
Jan-03-24 | Initiated | Barclays | Equal Weight |
Sep-06-23 | Initiated | HSBC Securities | Hold |
Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
Sep-19-22 | Downgrade | Argus | Buy → Hold |
Aug-22-22 | Resumed | Morgan Stanley | Overweight |
Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
Jan-11-21 | Upgrade | Argus | Hold → Buy |
Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Jun-02-20 | Resumed | Deutsche Bank | Buy |
May-15-20 | Upgrade | Mizuho | Neutral → Buy |
Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
Jan-08-20 | Initiated | Wells Fargo | Overweight |
Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
Jan-17-19 | Initiated | UBS | Buy |
Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
Oct-30-18 | Downgrade | Argus | Buy → Hold |
Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
Oct-19-18 | Resumed | BofA/Merrill | Buy |
Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Labcorp Will Face Claims It Sent Patient Data To Google, Meta - Bloomberg Law
Labcorp's SWOT analysis: acquisition strategy boosts growth amid stock surge - Investing.com India
Labcorp Holdings Inc.'s (NYSE:LH) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Simply Wall St
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
How Is Labcorp Holdings’ Stock Performance Compared to Other Healthcare Stocks? - Nasdaq
Labcorp Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
How Is Labcorp Holdings’ Stock Performance Compared to Other Healthcare Stocks? - MSN
How Is Labcorp Holdings’ Stock Performance Compared To Other Healthcare Stocks? - Barchart
Labcorp to Announce Third Quarter Financial Results on October 24, 2024 - Kilgore News Herald
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Labcorp to Announce Third Quarter Financial Results on October 24, 2024 - BioSpace
Labcorp to Announce Third Quarter Financial Results on October 24, 2024 - The Malaysian Reserve
Labcorp to Announce Third Quarter Financial Results on October 24, 2024 - Marketscreener.com
Labcorp to Announce Third Quarter Financial Results on October 24, 2024 - StockTitan
Labcorp secures $2 billion in senior notes By Investing.com - Investing.com Australia
Labcorp secures $2 billion in senior notes By Investing.com - Investing.com Canada
Labcorp secures $2 billion in senior notes - Investing.com
Jefferies sees LabCorp stock surging as M&A and diagnostics kick in - Investing.com Canada
Labcorp Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Labcorp Stock Gains From Its Latest Acquisition of BioReference Health - MSN
Labcorp laying off 53 employees, closing recently acquired laboratory - Houston Business Journal
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
LAB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
CommonWell Health Alliance Welcomes Labcorp as Newest Member - Yahoo Finance
Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience - Quantisnow
loanDepot (NYSE:LDI) Sees Large Volume Increase - MarketBeat
Labcorp Holdings Inc. (LH) may enjoy gains as insiders got busy in the recent days - Knox Daily
LabCorp slashes workforce in Melbourne after $237.5 million acquisition - The Business Journals
7 health systems selling lab assets - Becker's Hospital Review
Labcorp Stock Gains From Its Latest Acquisition of BioReference Health - Yahoo Finance
Was anything positive for Standard BioTools Inc (LAB) stock last session? - US Post News
Market Recap: Standard BioTools Inc (LAB)’s Positive Momentum, Closing at 2.09 - The Dwinnex
Cinven sells stake in SYNLAB to US-based Labcorp - LaingBuisson
Leerink Partnrs Comments on Laboratory Co. of America Holdings' FY2024 Earnings (NYSE:LH) - MarketBeat
Los Angeles Capital Management LLC Buys Shares of 12,763 LifeMD, Inc. (NASDAQ:LFMD) - Defense World
LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034 - StreetInsider.com
LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034 - PR Newswire
LoanDepot Inc [LDI] Insider Hsieh Anthony Li sells 480,088 Shares - Knox Daily
TD Cowen maintains Buy rating on Standard BioTools stock - Investing.com
Standard BioTools Inc (LAB) expanding its growth trajectory ahead - SETE News
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health - BioSpace
Labcorp Completes Acquisition Of Select Assets Of Bioreference Health's Diagnostics Business From Opko Health - XM
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health - PR Newswire
Indo-Asian News Service - IANS India Pvt Ltd
Prudential PLC Sells 7,956 Shares of Laboratory Co. of America Holdings (NYSE:LH) - MarketBeat
Taking a look at what insiders are doing to gauge the Standard BioTools Inc (LAB)’s direction - Knox Daily
Labcorp Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
Labcorp Stock Gains From Market Expansion Efforts Amid Macro Woes - MSN
When Should You Buy Labcorp Holdings Inc. (NYSE:LH)? - Simply Wall St
Pharmaceutical CDMO Market Size to Achieve USD 345.6 Billion by 2033 - GlobeNewswire Inc.
Laboratory Corporation: Difficult To Eye Long-Term Compounding Ability - Seeking Alpha
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):